{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aflatoxin B1", "Hepatitis B virus X protein", "Hepatotoxicity", "Liver cancer", "Pregnane X receptor"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34447675", "DateRevised": {"Year": "2022", "Month": "04", "Day": "26"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "04", "Day": "19"}], "Language": ["eng"], "ELocationID": ["10.14218/JCTH.2021.00036"], "Journal": {"ISSN": "2225-0719", "JournalIssue": {"Volume": "9", "Issue": "4", "PubDate": {"Year": "2021", "Month": "Aug", "Day": "28"}}, "Title": "Journal of clinical and translational hepatology", "ISOAbbreviation": "J Clin Transl Hepatol"}, "ArticleTitle": "Interaction of Hepatitis B Virus X Protein with the Pregnane X Receptor Enhances the Synergistic Effects of Aflatoxin B1 and Hepatitis B Virus on Promoting Hepatocarcinogenesis.", "Pagination": {"StartPage": "466", "EndPage": "476", "MedlinePgn": "466-476"}, "Abstract": {"AbstractText": ["Hepatitis B virus (HBV) infection has been found to increase hepatocellular sensitivity to carcinogenic xenobiotics, by unknown mechanisms, in the generation of hepatocellular carcinoma. The pregnane X receptor (PXR) is a key regulator of the body's defense against xenobiotics, including xenobiotic carcinogens and clinical drugs. In this study, we aimed to investigate the molecular mechanisms of HBV X protein (HBx)-PXR signaling in the synergistic effects of chemical carcinogens in HBV-associated hepatocarcinogenesis.", "The expression profile of PXR-cytochrome p450 3A4 (CYP3A4) signaling was determined by PCR, western blotting, and tissue microarray. Cell viability and aflatoxin B1 (AFB1) cytotoxicity were measured using the cell counting kit-8 assay. Target gene expression was evaluated using transient transfection and real time-PCR. The genotoxicity of AFB1 was assessed in newborn mice with a single dose of AFB1.", "HBx enhanced the hepatotoxicity of AFB1 by activating CYP3A4 and reducing glutathione S-transferase Mu 1 (GSTM1) in cell lines. Activation of PXR by pregnenolone 16\u03b1-carbonitrile increased AFB1-induced liver tumor incidence by up-regulating oncogenic KRAS to enhance interleukin (IL)-11:IL-11 receptor subunit alpha-1 (IL11RA-1)-mediated inflammation in an HBx transgenic model.", "Our finding regarding AFB1 toxicity enhancement by an HBx-PXR-CYP3A4/ GSTM1-KRAS-IL11:IL11RA signaling axis provides a rational explanation for the synergistic effects of chemical carcinogens in HBV infection-associated hepatocarcinogenesis."], "CopyrightInformation": "\u00a9 2021 Authors."}, "AuthorList": [{"Identifier": ["0000-0002-5392-3736"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, China."}], "LastName": "Niu", "ForeName": "Yongdong", "Initials": "Y"}, {"Identifier": ["0000-0003-1878-5902"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Key Laboratory for Biotechnology on Medicinal Plants of Jiangsu Province, School of Life Science, Jiangsu Normal University, Xuzhou, Jiangsu, China."}], "LastName": "Fan", "ForeName": "Shaohua", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}], "LastName": "Luo", "ForeName": "Qin", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Oncology, First Affiliated Hospital of Shantou University Medical College, Shantou, Guangdong, China."}], "LastName": "Chen", "ForeName": "Liming", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, China."}], "LastName": "Huang", "ForeName": "Danmei", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Environmental Hygiene, Second Military Medical University, Shanghai, China."}], "LastName": "Chang", "ForeName": "Wenjun", "Initials": "W"}, {"Identifier": ["0000-0002-1989-3027"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China."}], "LastName": "Qin", "ForeName": "Wenxin", "Initials": "W"}, {"Identifier": ["0000-0002-6856-1192"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Shantou University Medical College, Shantou, Guangdong, China."}], "LastName": "Shi", "ForeName": "Ganggang", "Initials": "G"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Clin Transl Hepatol", "NlmUniqueID": "101649815", "ISSNLinking": "2225-0719"}, "CoiStatement": "The authors have no conflict of interests related to this publication."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Villanueva A. Hepatocellular Carcinoma. N Engl J Med. 2019;380(15):1450\u20131462. doi: 10.1056/NEJMra1713263.", "ArticleIdList": ["10.1056/NEJMra1713263", "30970190"]}, {"Citation": "Jiang Y, Sun A, Zhao Y, Ying W, Sun H, Yang X, et al. Proteomics identifies new therapeutic targets of early-stage hepatocellular carcinoma. Nature. 2019;567(7747):257\u2013261. doi: 10.1038/s41586-019-0987-8.", "ArticleIdList": ["10.1038/s41586-019-0987-8", "30814741"]}, {"Citation": "Kensler TW, Chen JG, Egner PA, Fahey JW, Jacobson LP, Stephenson KK, et al. Effects of glucosinolate-rich broccoli sprouts on urinary levels of aflatoxin-DNA adducts and phenanthrene tetraols in a randomized clinical trial in He Zuo township, Qidong, People\u2019s Republic of China. Cancer Epidemiol Biomarkers Prev. 2005;14(11 Pt 1):2605\u20132613. doi: 10.1158/1055-9965.EPI-05-0368.", "ArticleIdList": ["10.1158/1055-9965.EPI-05-0368", "16284385"]}, {"Citation": "Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362(9399):1907\u20131917. doi: 10.1016/S0140-6736(03)14964-1.", "ArticleIdList": ["10.1016/S0140-6736(03)14964-1", "14667750"]}, {"Citation": "Kamdem LK, Meineke I, G\u00f6dtel-Armbrust U, Brockm\u00f6ller J, Wojnowski L. Dominant contribution of P450 3A4 to the hepatic carcinogenic activation of aflatoxin B1. Chem Res Toxicol. 2006;19(4):577\u2013586. doi: 10.1021/tx050358e.", "ArticleIdList": ["10.1021/tx050358e", "16608170"]}, {"Citation": "Zhang W, He H, Zang M, Wu Q, Zhao H, Lu LL, et al. Genetic features of aflatoxin-associated hepatocellular carcinoma. Gastroenterology. 2017;153(1):249\u2013262.e2. doi: 10.1053/j.gastro.2017.03.024.", "ArticleIdList": ["10.1053/j.gastro.2017.03.024", "28363643"]}, {"Citation": "Qian GS, Ross RK, Yu MC, Yuan JM, Gao YT, Henderson BE, et al. A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai, People\u2019s Republic of China. Cancer Epidemiol Biomarkers Prev. 1994;3(1):3\u201310.", "ArticleIdList": ["8118382"]}, {"Citation": "Kensler TW, Qian GS, Chen JG, Groopman JD. Translational strategies for cancer prevention in liver. Nat Rev Cancer. 2003;3(5):321\u2013329. doi: 10.1038/nrc1076.", "ArticleIdList": ["10.1038/nrc1076", "12724730"]}, {"Citation": "Kotiya D, Jaiswal B, Ghose S, Kaul R, Datta K, Tyagi RK. Role of PXR in hepatic cancer: Its influences on liver detoxification capacity and cancer progression. PLoS One. 2016;11(10):e0164087. doi: 10.1371/journal.pone.0164087.", "ArticleIdList": ["10.1371/journal.pone.0164087", "PMC5070842", "27760163"]}, {"Citation": "Xing Y, Yan J, Niu Y. PXR: a center of transcriptional regulation in cancer. Acta Pharm Sin B. 2020;10(2):197\u2013206. doi: 10.1016/j.apsb.2019.06.012.", "ArticleIdList": ["10.1016/j.apsb.2019.06.012", "PMC7016272", "32082968"]}, {"Citation": "Shen YH, Chen S, Peng YF, Shi YH, Huang XW, Yang GH, et al. Quantitative assessment of the effect of glutathione S-transferase genes GSTM1 and GSTT1 on hepatocellular carcinoma risk. Tumour Biol. 2014;35(5):4007\u20134015. doi: 10.1007/s13277-013-1524-2.", "ArticleIdList": ["10.1007/s13277-013-1524-2", "24399650"]}, {"Citation": "Niu Y, Xu M, Slagle BL, Huang H, Li S, Guo GL, et al. Farnesoid X receptor ablation sensitizes mice to hepatitis b virus X protein-induced hepatocarcinogenesis. Hepatology. 2017;65(3):893\u2013906. doi: 10.1002/hep.28924.", "ArticleIdList": ["10.1002/hep.28924", "PMC5319891", "28102638"]}, {"Citation": "Madden CR, Finegold MJ, Slagle BL. Altered DNA mutation spectrum in aflatoxin b1-treated transgenic mice that express the hepatitis B virus x protein. J Virol. 2002;76(22):11770\u201311774. doi: 10.1128/jvi.76.22.11770-11774.2002.", "ArticleIdList": ["10.1128/jvi.76.22.11770-11774.2002", "PMC136763", "12388740"]}, {"Citation": "Wang Y, Cui F, Lv Y, Li C, Xu X, Deng C, et al. HBsAg and HBx knocked into the p21 locus causes hepatocellular carcinoma in mice. Hepatology. 2004;39(2):318\u2013324. doi: 10.1002/hep.20076.", "ArticleIdList": ["10.1002/hep.20076", "14767984"]}, {"Citation": "Niu Y, Wu Z, Shen Q, Song J, Luo Q, You H, et al. Hepatitis B virus X protein co-activates pregnane X receptor to induce the cytochrome P450 3A4 enzyme, a potential implication in hepatocarcinogenesis. Dig Liver Dis. 2013;45(12):1041\u20131048. doi: 10.1016/j.dld.2013.06.004.", "ArticleIdList": ["10.1016/j.dld.2013.06.004", "23891548"]}, {"Citation": "Xie W, Radominska-Pandya A, Shi Y, Simon CM, Nelson MC, Ong ES, et al. An essential role for nuclear receptors SXR/PXR in detoxification of cholestatic bile acids. Proc Natl Acad Sci U S A. 2001;98(6):3375\u20133380. doi: 10.1073/pnas.051014398.", "ArticleIdList": ["10.1073/pnas.051014398", "PMC30661", "11248086"]}, {"Citation": "Fox JG, Feng Y, Theve EJ, Raczynski AR, Fiala JL, Doernte AL, et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut. 2010;59(1):88\u201397. doi: 10.1136/gut.2009.183749.", "ArticleIdList": ["10.1136/gut.2009.183749", "PMC3891362", "19850960"]}, {"Citation": "Lian Q, Wang S, Zhang G, Wang D, Luo G, Tang J, et al. HCCDB: A database of hepatocellular carcinoma expression atlas. Genomics Proteomics Bioinformatics. 2018;16(4):269\u2013275. doi: 10.1016/j.gpb.2018.07.003.", "ArticleIdList": ["10.1016/j.gpb.2018.07.003", "PMC6205074", "30266410"]}, {"Citation": "Sohn S, Jaitovitch-Groisman I, Benlimame N, Galipeau J, Batist G, Alaoui-Jamali MA. Retroviral expression of the hepatitis B virus x gene promotes liver cell susceptibility to carcinogen-induced site specific mutagenesis. Mutat Res. 2000;460(1):17\u201328. doi: 10.1016/s0921-8777(00)00010-0.", "ArticleIdList": ["10.1016/s0921-8777(00)00010-0", "10856831"]}, {"Citation": "Langou\u00ebt S, Coles B, Morel F, Becquemont L, Beaune P, Guengerich FP, et al. Inhibition of CYP1A2 and CYP3A4 by oltipraz results in reduction of aflatoxin B1 metabolism in human hepatocytes in primary culture. Cancer Res. 1995;55(23):5574\u20135579.", "ArticleIdList": ["7585637"]}, {"Citation": "Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, et al. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, People\u2019s Republic of China. J Natl Cancer Inst. 1999;91(4):347\u2013354. doi: 10.1093/jnci/91.4.347.", "ArticleIdList": ["10.1093/jnci/91.4.347", "10050868"]}, {"Citation": "Guengerich FP, Johnson WW, Shimada T, Ueng YF, Yamazaki H, Langou\u00ebt S. Activation and detoxication of aflatoxin B1. Mutat Res. 1998;402(1-2):121\u2013128. doi: 10.1016/s0027-5107(97)00289-3.", "ArticleIdList": ["10.1016/s0027-5107(97)00289-3", "9675258"]}, {"Citation": "Ilic Z, Crawford D, Vakharia D, Egner PA, Sell S. Glutathione-S-transferase A3 knockout mice are sensitive to acute cytotoxic and genotoxic effects of aflatoxin B1. Toxicol Appl Pharmacol. 2010;242(3):241\u2013246. doi: 10.1016/j.taap.2009.10.008.", "ArticleIdList": ["10.1016/j.taap.2009.10.008", "PMC2813954", "19850059"]}, {"Citation": "Shin SY, Choi C, Lee HG, Lim Y, Lee YH. Transcriptional regulation of the interleukin-11 gene by oncogenic Ras. Carcinogenesis. 2012;33(12):2467\u20132476. doi: 10.1093/carcin/bgs297.", "ArticleIdList": ["10.1093/carcin/bgs297", "23027619"]}, {"Citation": "Widjaja AA, Singh BK, Adami E, Viswanathan S, Dong J, D\u2019Agostino GA, et al. Inhibiting interleukin 11 signaling reduces hepatocyte death and liver fibrosis, inflammation, and steatosis in mouse models of nonalcoholic steatohepatitis. Gastroenterology. 2019;157(3):777\u2013792.e14. doi: 10.1053/j.gastro.2019.05.002.", "ArticleIdList": ["10.1053/j.gastro.2019.05.002", "31078624"]}, {"Citation": "Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM, et al. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 2007;317(5834):121\u2013124. doi: 10.1126/science.1140485.", "ArticleIdList": ["10.1126/science.1140485", "17615358"]}, {"Citation": "Schmidt-Arras D, Rose-John S. IL-6 pathway in the liver: From physiopathology to therapy. J Hepatol. 2016;64(6):1403\u20131415. doi: 10.1016/j.jhep.2016.02.004.", "ArticleIdList": ["10.1016/j.jhep.2016.02.004", "26867490"]}, {"Citation": "Arzumanyan A, Reis HM, Feitelson MA. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat Rev Cancer. 2013;13(2):123\u2013135. doi: 10.1038/nrc3449.", "ArticleIdList": ["10.1038/nrc3449", "23344543"]}, {"Citation": "Zhao LH, Liu X, Yan HX, Li WY, Zeng X, Yang Y, et al. Genomic and oncogenic preference of HBV integration in hepatocellular carcinoma. Nat Commun. 2016;7:12992. doi: 10.1038/ncomms12992.", "ArticleIdList": ["10.1038/ncomms12992", "PMC5059470", "27703150"]}, {"Citation": "Jiang DK, Sun J, Cao G, Liu Y, Lin D, Gao YZ, et al. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat Genet. 2013;45(1):72\u201375. doi: 10.1038/ng.2483.", "ArticleIdList": ["10.1038/ng.2483", "PMC4105840", "23242368"]}, {"Citation": "Huang J, Deng Q, Wang Q, Li KY, Dai JH, Li N, et al. Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet. 2012;44(10):1117\u20131121. doi: 10.1038/ng.2391.", "ArticleIdList": ["10.1038/ng.2391", "22922871"]}, {"Citation": "Lereau M, Gouas D, Villar S, Besaratinia A, Hautefeuille A, Berthillon P, et al. Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells. J Gen Virol. 2012;93(Pt 3):640\u2013650. doi: 10.1099/vir.0.032482-0.", "ArticleIdList": ["10.1099/vir.0.032482-0", "22113009"]}, {"Citation": "Sun Z, Lu P, Gail MH, Pee D, Zhang Q, Ming L, et al. Increased risk of hepatocellular carcinoma in male hepatitis B surface antigen carriers with chronic hepatitis who have detectable urinary aflatoxin metabolite M1. Hepatology. 1999;30(2):379\u2013383. doi: 10.1002/hep.510300204.", "ArticleIdList": ["10.1002/hep.510300204", "10421643"]}, {"Citation": "Li CH, Wang YJ, Dong W, Xiang S, Liang HF, Wang HY, et al. Hepatic oval cell lines generate hepatocellular carcinoma following transfection with HBx gene and treatment with aflatoxin B1 in vivo. Cancer Lett. 2011;311(1):1\u201310. doi: 10.1016/j.canlet.2011.05.035.", "ArticleIdList": ["10.1016/j.canlet.2011.05.035", "21821357"]}, {"Citation": "Lu JW, Yang WY, Lin YM, Jin SL, Yuh CH. Hepatitis B virus X antigen and aflatoxin B1 synergistically cause hepatitis, steatosis and liver hyperplasia in transgenic zebrafish. Acta Histochem. 2013;115(7):728\u2013739. doi: 10.1016/j.acthis.2013.02.012.", "ArticleIdList": ["10.1016/j.acthis.2013.02.012", "23499292"]}, {"Citation": "Cheng J, Ma X, Krausz KW, Idle JR, Gonzalez FJ. Rifampicin-activated human pregnane X receptor and CYP3A4 induction enhance acetaminophen-induced toxicity. Drug Metab Dispos. 2009;37(8):1611\u20131621. doi: 10.1124/dmd.109.027565.", "ArticleIdList": ["10.1124/dmd.109.027565", "PMC2712435", "19460945"]}, {"Citation": "Du J, Xing Q, Xu L, Xu M, Shu A, Shi Y, et al. Systematic screening for polymorphisms in the CYP3A4 gene in the Chinese population. Pharmacogenomics. 2006;7(6):831\u2013841. doi: 10.2217/14622416.7.6.831.", "ArticleIdList": ["10.2217/14622416.7.6.831", "16981844"]}, {"Citation": "Jeannot E, Boorman GA, Kosyk O, Bradford BU, Shymoniak S, Tumurbaatar B, et al. Increased incidence of aflatoxin B1-induced liver tumors in hepatitis virus C transgenic mice. Int J Cancer. 2012;130(6):1347\u20131356. doi: 10.1002/ijc.26140.", "ArticleIdList": ["10.1002/ijc.26140", "PMC3161148", "21500192"]}, {"Citation": "Knasm\u00fcller S, Parzefall W, Sanyal R, Ecker S, Schwab C, Uhl M, et al. Use of metabolically competent human hepatoma cells for the detection of mutagens and antimutagens. Mutat Res. 1998;402(1-2):185\u2013202. doi: 10.1016/s0027-5107(97)00297-2.", "ArticleIdList": ["10.1016/s0027-5107(97)00297-2", "9675276"]}, {"Citation": "Kirby GM, Batist G, Alpert L, Lamoureux E, Cameron RG, Alaoui-Jamali MA. Overexpression of cytochrome P-450 isoforms involved in aflatoxin B1 bioactivation in human liver with cirrhosis and hepatitis. Toxicol Pathol. 1996;24(4):458\u2013467. doi: 10.1177/019262339602400408.", "ArticleIdList": ["10.1177/019262339602400408", "8864187"]}, {"Citation": "Kirby GM, Chemin I, Montesano R, Chisari FV, Lang MA, Wild CP. Induction of specific cytochrome P450s involved in aflatoxin B1 metabolism in hepatitis B virus transgenic mice. Mol Carcinog. 1994;11(2):74\u201380. doi: 10.1002/mc.2940110204.", "ArticleIdList": ["10.1002/mc.2940110204", "7916995"]}, {"Citation": "Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, et al. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95(19):1485\u20131488. doi: 10.1093/jnci/djg051.", "ArticleIdList": ["10.1093/jnci/djg051", "14519756"]}, {"Citation": "Cui JY, Gunewardena SS, Rockwell CE, Klaassen CD. ChIPing the cistrome of PXR in mouse liver. Nucleic Acids Res. 2010;38(22):7943\u20137963. doi: 10.1093/nar/gkq654.", "ArticleIdList": ["10.1093/nar/gkq654", "PMC3001051", "20693526"]}, {"Citation": "Moscovitz JE, Kalgutkar AS, Nulick K, Johnson N, Lin Z, Goosen TC, et al. Establishing transcriptional signatures to differentiate PXR-, CAR-, and AhR-mediated regulation of drug metabolism and transport genes in cryopreserved human hepatocytes. J Pharmacol Exp Ther. 2018;365(2):262\u2013271. doi: 10.1124/jpet.117.247296.", "ArticleIdList": ["10.1124/jpet.117.247296", "29440451"]}, {"Citation": "McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, et al. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003;63(15):4594\u20134601.", "ArticleIdList": ["12907637"]}, {"Citation": "Lian M, Liu Y, Yu SZ, Qian GS, Wan SG, Dixon KR. Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice. World J Gastroenterol. 2006;12(19):3065\u20133072. doi: 10.3748/wjg.v12.i19.3065.", "ArticleIdList": ["10.3748/wjg.v12.i19.3065", "PMC4124383", "16718789"]}, {"Citation": "Chomarat P, Rice JM, Slagle BL, Wild CP. Hepatitis B virus-induced liver injury and altered expression of carcinogen metabolising enzymes: the role of the HBx protein. Toxicol Lett. 1998;102-103:595\u2013601. doi: 10.1016/s0378-4274(98)00254-9.", "ArticleIdList": ["10.1016/s0378-4274(98)00254-9", "10022319"]}, {"Citation": "Stern MC, Umbach DM, Yu MC, London SJ, Zhang ZQ, Taylor JA. Hepatitis B, aflatoxin B(1), and p53 codon 249 mutation in hepatocellular carcinomas from Guangxi, People\u2019s Republic of China, and a meta-analysis of existing studies. Cancer Epidemiol Biomarkers Prev. 2001;10(6):617\u2013625.", "ArticleIdList": ["11401911"]}, {"Citation": "Gross-Steinmeyer K, Stapleton PL, Tracy JH, Bammler TK, Strom SC, Eaton DL. Sulforaphane- and phenethyl isothiocyanate-induced inhibition of aflatoxin B1-mediated genotoxicity in human hepatocytes: role of GSTM1 genotype and CYP3A4 gene expression. Toxicol Sci. 2010;116(2):422\u2013432. doi: 10.1093/toxsci/kfq135.", "ArticleIdList": ["10.1093/toxsci/kfq135", "PMC2905401", "20442190"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "1", "Day": "20"}, {"Year": "2021", "Month": "2", "Day": "24"}, {"Year": "2021", "Month": "3", "Day": "18"}, {"Year": "2021", "Month": "8", "Day": "27", "Hour": "6", "Minute": "57"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "8", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "4", "Day": "19"}], "PublicationStatus": "ppublish", "ArticleIdList": ["34447675", "PMC8369009", "10.14218/JCTH.2021.00036", "JCTH.2021.00036"]}}], "PubmedBookArticle": []}